As of September 29, 2026, Indaptus Therapeutics's top three insider holders are Jeffrey A Meckler (Co Chief Executive Officer, 229.93K shares), Michael James Newman (Cso And Director, 101.07K shares), Walt Addison Linscott (Chief Operating Officer, 54.43K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Jeffrey A Meckler | Co Chief Executive Officer | 230,020 | 0 | 230,020 | 52.5% | 29 Dec, 2025 |
| 2 | Michael James Newman | Cso And Director | 101,074 | 0 | 101,074 | 23.1% | 29 Dec, 2025 |
| 3 | Walt Addison Linscott | Chief Operating Officer | 54,426 | 0 | 54,426 | 12.4% | 29 Dec, 2025 |
| 4 | Nir Sassi | Chief Financial Officer | 26,758 | 0 | 26,758 | 6.1% | 29 Dec, 2025 |
| 5 | Avraham Ben-Tzvi | Director | 25,100 | 0 | 25,100 | 5.7% | 22 Jan, 2026 |
| 6 | Glen R. Anderson | TenPercentOwner | 0 | 531 | 531 | 0.1% | 16 Aug, 2023 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 23 Mar, 2026 | David E. Lazar | Director | Disposed S | 196,800 | — | — | 103,200 | Direct |
| 23 Mar, 2026 | David E. Lazar | Director | Disposed S | 700,000 | — | — | 0 | Direct |
| 26 Feb, 2026 | Jerome D Jabbour | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 11 Feb, 2026 | Jeffrey A Meckler | Co Chief Executive Officer | Disposed D | 3,033 | — | — | 0 | Direct |
| 11 Feb, 2026 | Jeffrey A Meckler | Co Chief Executive Officer | Acquired A | 3,033 | — | — | 3,033 | Direct |
| 11 Feb, 2026 | Jeffrey A Meckler | Co Chief Executive Officer | Disposed D | 1,519 | — | — | 0 | Direct |
| 11 Feb, 2026 | Jeffrey A Meckler | Co Chief Executive Officer | Acquired A | 1,519 | — | — | 1,519 | Direct |
| 11 Feb, 2026 | Jeffrey A Meckler | Co Chief Executive Officer | Disposed D | 12,136 | — | — | 0 | Direct |
| 11 Feb, 2026 | Jeffrey A Meckler | Co Chief Executive Officer | Acquired A | 12,136 | — | — | 12,136 | Direct |
| 20 Jan, 2026 | Avraham Ben-Tzvi | Director | Acquired A | 25,000 | $0.00 | $0 | 25,100 | Direct |
| 07 Jan, 2026 | David Natan | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 23 Dec, 2025 | Avraham Ben-Tzvi | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 22 Dec, 2025 | Michael James Newman | Cso And Director | Acquired A | 52,204 | $2.03 | $105.97K | 101,074 | Direct |
| 22 Dec, 2025 | Nir Sassi | Chief Financial Officer | Acquired A | 26,758 | $2.03 | $54.32K | 26,758 | Direct |
| 22 Dec, 2025 | Jeffrey A Meckler | Co Chief Executive Officer | Acquired A | 216,617 | $2.03 | $439.73K | 229,929 | Direct |
| 22 Dec, 2025 | Walt Addison Linscott | Chief Operating Officer | Acquired A | 54,421 | $2.03 | $110.47K | 54,426 | Direct |
| 27 Jul, 2025 | Jeffrey A Meckler | Chief Executive Officer | Acquired A | 6,068 | $8.30 | $50.38K | 13,312 | Direct |
| 27 Jul, 2025 | Jeffrey A Meckler | Chief Executive Officer | Acquired A | 12,136 | $8.30 | $100.76K | 16,688 | Direct |
| 10 Jun, 2025 | Robert Martell | Director | Acquired A | 12,500 | $0.00 | $0 | 6 | Direct |
| 10 Jun, 2025 | William B Hayes | Director | Acquired A | 12,500 | $0.00 | $0 | 6 | Direct |